StreetAccount Summary: Stocks reaching new 52-week highs/lows (122 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (120 total)
StreetAccount Summary: Stocks reaching new 52-week highs/lows (125 total)
Immunocore presents Phase 1 data for IMC-I109V at AASLD's The Liver Meeting ($31.60, 0.00)
Immunocore Holdings reports Q3 EPS $0.00 vs FactSet ($0.23) [17 est, ($0.51)-0.10] ($30.80, 0.00)
Immunocore Holdings initiated overweight at Wells Fargo Securities ($32.19, 0.00)
Powered by FactSet Research Systems Inc.